CORT
CORCEPT THERAPEUTICS INC
NASDAQ · Healthcare · Biotechnology · US
$87.75
−18.38%Forward multiples
Based on analyst estimates
- P/E forward
- 18.58x
- P/E 2026E
- 45.62x
- P/E 2027E
- 21.64x
- P/E 2028E
- 13.32x
- P/S forward
- 5.77x
Trailing multiples
Trailing twelve months
- P/E TTM
- 168.74x
- PEG TTM
- 0.22x
- Price / book
- 13.44x
- Price / sales
- 11.42x
- Price / cash flow
- 86.46x
Enterprise value
- Enterprise value
- $9.2B
- EV / sales
- 11.06x
- EV / EBITDA
- 319.09x
- EV / EBIT
- 1434.24x
- Market cap
- $9.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026